This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

5 Stocks Insiders Love Right Now

Stocks in this article: FRXSONSTCXEQYPLCE

Forest Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders are buying up a large amount of stock in Forest Laboratories (FRX), which develops, manufactures and sells branded forms of ethical drug products, most of which require a physician's prescription. Insiders are loading up on this stock into some modest strength, since shares are up over 14% so far in 2012.

Forest Laboratories has a market cap of $9.22 billion and an enterprise value of $6.65 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 12.05 and a forward price-to-earnings of 22.54. Its estimated growth rate for this year is -81.7%, and for next year it's pegged at 126.5%. This is an extremely cash-rich company, since the total cash position on its balance sheet is $2.5 billion and its total debt is zero.

>>5 Pharma Stocks Everyone Hates

Billionaire hedge fund manager and beneficial owner Carl Icahn just bought 1,962,011 shares, or about $67.05 million worth of stock, at $33.97 to $34.35 per share.

From a technical perspective, FRX is currently trading above both its 50-day and 200-day moving averages, which is bullish. Shares of FRX recently sold off from a high of $36.44 to a low of $31.28 with some above average selling volume. Following that low, shares of FRX have started to ramp higher and move back above both its 50-day and 200-day moving averages. That move has now pushed FRX back inside of its uptrend that had been intact before the recent selloff.

If you're bullish on FRX, then I would look for long-biased trades as long as this stock is trending above its 50-day moving average of $34.40 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average volume of 1.9 million shares as bullish. If FRX can maintain that trend, then this stock has a great chance of re-testing and possibly taking out its recent high of $36.44 a share.

On the flipside, I would avoid FRX or look for short-biased trades if this stock fails to hold that trend, and then drops back below some near-term support at $33.50 a share with heavy volume. If we see that action soon, then look for FRX to re-test and possibly take out its 200-day moving average of $32.80 a share.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,828.24 +0.49 0.00%
S&P 500 2,067.56 -5.27 -0.25%
NASDAQ 4,791.63 +4.3130 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs